Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer

PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Urol
Hoofdauteurs: Tsai, Huei-Ting, Keating, Nancy L., Van Den Eeden, Stephen K., Haque, Reina, Cassidy-Bushrow, Andrea E., Yood, Marianne Ulcickas, Smith, Matthew R., Potosky, Arnold L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/
https://ncbi.nlm.nih.gov/pubmed/25524243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items